Diseases, Free Full-Text

Colorectal cancer (CRC) is the third most common cancer worldwide. A diagnosis at early stages with enhanced screening methods is vital as metastases and recurrences increase mortality. The aim of this study was to analyze the tumor markers CEA and CA19-9 combined in correlation with diagnostics and prognosis. Therefore, 1487 patients with CRC who were diagnosed and treated between 2000 and 2015 at the University Hospital Ulm, Germany, were retrospectively evaluated. Overall and recurrence-free survival was analyzed in association with preoperative CEA and CA19-9 separately and combined and a multivariate analysis was performed. The 5-year overall survival was significantly shorter in patients with a CEA or CA19-9 level ≥200 compared to patients with an increased, but <200, or normal level (CEA: 69%/44%/7%; CA19-9: 66%/38%/8%). Patients with both tumor markers increased also showed a remarkably shorter 5-year survival rate (CEA+/CA19-9+: 23%). The multivariate analysis emphasizes these results (p-value < 0.0001). Patients with both tumor markers elevated had the shortest 5-year recurrence-free survival rate, followed by patients with either CEA or CA19-9 elevated (CEA-/CA19-9-: 79%; CEA+/CA19-9; CEA-/CA19-9+: 65%; CEA+/CA19-9+: 44%). In conclusion, measuring CEA and CA19-9 preoperatively in CRC patients is reasonable and could be useful as a prognostic factor.

Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 - The Lancet

Idiopathic Diseases: Nature, Types and Impact

Full article: Safety profiles of biologic agents for inflammatory bowel diseases: a prospective pharmacovigilance study in Southern Italy

Treatment of Venereal Diseases - Dion R. Bell, 1973

Buy Eat So What! The Power of Vegetarianism Volume 1 (Full Color Print): Nutrition Guide For Weight Loss, Disease Free, Drug Free, Healthy Long Life Book Online at Low Prices in India

Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019 - The Lancet Public Health

RePub, Erasmus University Repository: Modeling human brain diseases using pluripotent stem cells

Empagliflozin in Patients with Chronic Kidney Disease

Clinical Infectious Diseases

Clinical Trials in Degenerative Diseases - Free full text articles from Clinical Trials in Degenerative Diseases

ESC Guidelines on Cardiovascular Diseases during Pregnancy (Management of)

Prevalence of access to treatment of chronic diseases in Brazil and

Spring cure. Doctor Quenaudon's extract of green herbs for purifying the blood and the cure of all diseases arising from its impurity, also of all other chronic diseases Dr. D. V.